Alterity Therapeutics Ltd (ATHE)
2.06
+0.05
(+2.49%)
USD |
NASDAQ |
May 07, 12:02
Alterity Therapeutics 1 Year Total Returns (Daily): -33.88% for May 6, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 06, 2024 | -33.88% |
May 03, 2024 | -24.63% |
May 02, 2024 | -20.74% |
May 01, 2024 | -20.86% |
April 30, 2024 | -25.18% |
April 29, 2024 | -21.60% |
April 26, 2024 | -10.36% |
April 25, 2024 | -20.26% |
April 24, 2024 | -17.81% |
April 23, 2024 | -26.82% |
April 22, 2024 | -26.82% |
April 19, 2024 | -29.90% |
April 18, 2024 | -26.46% |
April 17, 2024 | -30.45% |
April 16, 2024 | -28.82% |
April 15, 2024 | -14.93% |
April 12, 2024 | 10.11% |
April 11, 2024 | -8.36% |
April 10, 2024 | -22.34% |
April 09, 2024 | -32.03% |
April 08, 2024 | -33.10% |
April 05, 2024 | -33.33% |
April 04, 2024 | -34.46% |
April 03, 2024 | -33.09% |
April 02, 2024 | -34.09% |
Date | Value |
---|---|
April 01, 2024 | -29.77% |
March 28, 2024 | -24.73% |
March 27, 2024 | -26.41% |
March 26, 2024 | -32.58% |
March 25, 2024 | -35.96% |
March 22, 2024 | -34.63% |
March 21, 2024 | -34.44% |
March 20, 2024 | -37.36% |
March 19, 2024 | -38.83% |
March 18, 2024 | -34.07% |
March 15, 2024 | -32.57% |
March 14, 2024 | -39.80% |
March 13, 2024 | -41.93% |
March 12, 2024 | -49.39% |
March 11, 2024 | -47.87% |
March 08, 2024 | -48.33% |
March 07, 2024 | -48.92% |
March 06, 2024 | -46.31% |
March 05, 2024 | -43.73% |
March 04, 2024 | -44.37% |
March 01, 2024 | -47.58% |
February 29, 2024 | -41.74% |
February 28, 2024 | -40.65% |
February 27, 2024 | -41.81% |
February 26, 2024 | -41.96% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-81.70%
Minimum
Mar 18 2020
350.0%
Maximum
Mar 22 2021
-17.11%
Average
-45.80%
Median
Oct 26 2023
1 Year Total Returns (Daily) Benchmarks
Kazia Therapeutics Ltd | -75.82% |
Immutep Ltd | 82.62% |
Opthea Ltd | -5.92% |
Mesoblast Ltd | 19.20% |
Immuron Ltd | 35.03% |